Whitmore-Jewett staging system (historical)
Updates to Article Attributes
Body
was changed:
Whitmore-Jewett staging system (also known as the Jewett staging system or ABCD system) is a staging system for prostate cancer. It was developed by the American Urological Association (AUA). Most societies (including AUA) and clinicians now advocate and use the TNM staging system.
-
A: subclinical tumour: found incidentally (T1 in TNM)
- A1: tissue resembles normal cells; found in a few chips from one lobe
- A2: more extensive involvement
-
B: tumour palpable on digital rectal exam (DRE): no extraprostatic extension (T2 in TNM)
- B1: less than 50% one lobe
- B2: more than 50% one lobe
- B3: both lobes
-
C: extracapsular extension (T3/T4 in TNM)
- C1: unilateral, not seminal vesicles (T3a)
-
C2
- bilateral, not seminal vesicles (T3b)
- seminal vesicles (T3c)
- bladder neck, external anal sphincter, and/or rectum (T4a)
- levator muscles, and/or fixed to pelvic side wall (T4b)
-
D: metastasis
- D1: regional adenopathy (N1 in TNM)
- D2: distant metastases (M staging in TNM)
-<p><strong>Whitmore-Jewett staging system</strong> (also known as the <strong>Jewett staging system</strong> or <strong>ABCD system</strong>) is a staging system for prostate cancer. It was developed by the American Urological Association (AUA). Most societies (including AUA) and clinicians now advocate and use the <a href="/articles/prostate-cancer-staging-1">TNM staging system</a>.</p><ul>- +<p><strong>Whitmore-Jewett staging system</strong> (also known as the <strong>Jewett staging system</strong> or <strong>ABCD system</strong>) is a staging system for <a title="Prostate cancer" href="/articles/prostatic-carcinoma-1">prostate cancer</a>. It was developed by the American Urological Association (AUA). Most societies (including AUA) and clinicians now advocate and use the <a href="/articles/prostate-cancer-staging-1">TNM staging system</a>.</p><ul>
Unable to process the form. Check for errors and try again.